Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells
about
PPARs and the cardiovascular systemTranscriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell functionVascular targets for cannabinoids: animal and human studiesThe dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.Peroxisome proliferator-activated receptors in the cardiovascular system.Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retentionPeroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.Coronary microvascular dysfunction in diabetes mellitus: A reviewDevelopment and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis.Molecular Implications of the PPARs in the Diabetic Eye.Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationPPAR-alpha effects on the heart and other vascular tissues.Peroxisome proliferator-activated receptors and cardiovascular remodeling.The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.Peroxisome proliferator-activated receptors in lung cancer.PPAR Agonists and Cardiovascular Disease in Diabetes.Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.Cardiovascular actions of the peroxisome proliferator-activated receptor-alpha (PPARalpha) agonist Wy14,643.Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseasesModulation of endothelial cell thrombomodulin by PPAR ligands--variation according to environment.Pharmacogenetics of the PPAR genes and cardiovascular disease.PPAR-alpha Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration.Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.Distinct functions of vascular endothelial and smooth muscle PPARgamma in regulation of blood pressure and vascular tone.Effect of fibrate treatment on liver function tests in patients with the metabolic syndrome.Advances in the medical treatment of diabetic retinopathy.HDL inflammation and atherosclerosis: current and future perspectives.Peroxisome proliferator-activated receptors and atherosclerosis.PPARs and their effects on the cardiovascular system.Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury.The pathological roles of environmental and redox stresses in cardiovascular diseases.Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.Macrophage polarization: the link between inflammation and related diseases.Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.Modulation peroxisome proliferators activated receptor alpha (PPAR alpha) and acyl coenzyme A: cholesterol acyltransferase1 (ACAT1) gene expression by fatty acids in foam cell.Renal and vascular mechanisms of thiazolidinedione-induced fluid retention.Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
P2860
Q24642728-7720BFA7-0009-4672-B403-616DE080D64CQ24803245-AA781FF8-DE5C-4BF6-891C-25713D47DB0DQ26862515-783FE353-1676-49C1-8D94-B0B2E27F1C90Q33562214-5E788E3C-B857-4C56-A9E8-47056ECDBF90Q33850995-93ABD110-93F7-4D98-A703-EE3BA639D954Q33878917-4F327124-72CE-4213-8125-1BEED8219EFEQ34290988-387C8A6E-3F5D-4204-8441-7D5EE68457C2Q34427072-68631C88-557C-4864-A139-C9F1C8154D6EQ34570740-F108ECC3-CC82-424E-BD04-47C93711D986Q34594935-D8197378-A3C2-4347-A906-BE6816653167Q35021504-15A3273B-5E0F-4547-800C-BDCF84CAB1BAQ35053566-01DDF5E4-DCE4-4678-8A1B-C27D0FD02B8DQ35080447-49BD5B9C-0997-4940-9907-29AA3989E584Q35890826-8F5C7994-3D0E-4FB0-9EC2-E0525A5C9FC0Q36326205-F22AACD9-7D00-45A4-A3ED-CFE8A92E9E4DQ36417658-37BB1869-4B7A-44D8-AB11-CF0D430FD508Q36444975-312DC248-6A58-4BCB-ADE4-2FB642A67E5BQ36509300-845956D7-FEB6-43BF-967B-BE1E76A4D0C3Q36512559-65818568-45E7-43B6-8FF4-63C27CC6D7B7Q36528512-88AB6D3A-605C-480E-BD59-DE0FA26921ABQ36872068-B2AAB6C4-5D1A-4F30-AEB5-30DF836101A9Q36918509-B5F63D05-0034-49A4-8C5E-825BE35DA62CQ36960958-0205DDB7-B423-4B1D-9018-ABD1B0E3D915Q37012017-753CC0F4-E6FA-4CD7-9A1B-3A6C35CED3A8Q37134028-70C82620-FA38-439D-9897-41E89DF399E3Q37231752-9F9F89EF-193D-42CD-868F-BB86B43F46A8Q37468639-4456D4F0-2398-4AF6-AC77-B79596224F20Q37484551-565D94E2-50E2-4565-85A1-8A6093CAE2E1Q37564793-EB72E555-A6FF-446C-9D57-E253E94E145AQ37608502-620DF3B7-CE98-4B6E-A49D-9E05B14B8B23Q37861955-2CB4B14B-7D69-4321-973F-40D097365BA9Q37896654-A540774D-DE6D-4CD1-927D-1B269DC02305Q37899155-08E2230C-9222-42B0-9CA3-60BF0CDE4FD1Q38070371-651374F9-047C-4D43-BB1B-ED2A79A64AA8Q38325827-5993CB5C-3A4F-42D9-9785-399048B07C0FQ38607431-4BDAA61C-B01A-4E69-A31E-0AF4D1BD6593Q39780799-1BE6749F-7DC4-418A-8374-E4F77AC8CDB3Q39804569-35A0D65A-8897-4176-BE30-929C8F4A76C8Q40048496-2DA109AB-10FA-4F54-A382-332F149CEEF3Q40341163-3611C8B5-A339-4144-A92B-BF1AA896DB72
P2860
Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Expression of peroxisome proli ...... man vascular endothelial cells
@ast
Expression of peroxisome proli ...... man vascular endothelial cells
@en
Expression of peroxisome proli ...... man vascular endothelial cells
@nl
type
label
Expression of peroxisome proli ...... man vascular endothelial cells
@ast
Expression of peroxisome proli ...... man vascular endothelial cells
@en
Expression of peroxisome proli ...... man vascular endothelial cells
@nl
prefLabel
Expression of peroxisome proli ...... man vascular endothelial cells
@ast
Expression of peroxisome proli ...... man vascular endothelial cells
@en
Expression of peroxisome proli ...... man vascular endothelial cells
@nl
P2093
P356
P1476
Expression of peroxisome proli ...... man vascular endothelial cells
@en
P2093
P304
P356
10.1006/BBRC.1998.8622
P407
P50
P577
1998-05-01T00:00:00Z